Protagonist Therapeutics, Inc (18) | Uncategorized (7)
Recent Contracts
-
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on February 28, 2022)
-
Arbitration Resolution Agreement, dated August 4th, 2021, by and among Protagonist Therapeutics, Inc. and Zealand Pharma, A/S
(Filed With SEC on November 3, 2021)
-
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 10, 2021)
-
Description of Protagonist Therapeutics, Inc.s Securities Registered Pursuant to Section 12 of the Exchange Act
(Filed With SEC on March 10, 2020)
-
Protagonist Therapeutics, Inc. Amended and Restated 2018 Inducement Plan
(Filed With SEC on February 24, 2020)
-
Open Market Sale AgreementSM, dated November 27, 2019, by and between Protagonist Therapeutics, Inc. and Jefferies LLC
(Filed With SEC on November 27, 2019)
-
Offer Letter between Protagonist Therapeutics, Inc. and Donald Kalkofen, dated May 20, 2019
(Filed With SEC on May 29, 2019)